These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6624754)

  • 1. Implementing guidelines for managing extravasation of antineoplastics.
    Hirsh JD; Conlon PF
    Am J Hosp Pharm; 1983 Sep; 40(9):1516-9. PubMed ID: 6624754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy program for improved handling of antineoplastic agents.
    Scott SA; Schrott DB; Loesch GA
    Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures for handling antineoplastic injections in comprehensive cancer centers.
    LeRoy ML; Roberts MJ; Theisen JA
    Am J Hosp Pharm; 1983 Apr; 40(4):601-3. PubMed ID: 6846366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital.
    Adami NP; de Gutiérrez MG; da Fonseca SM; de Almeida EP
    J Clin Nurs; 2005 Aug; 14(7):876-82. PubMed ID: 16000102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
    Sauerland C; Engelking C; Wickham R; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic admixture service in a tertiary-care hospital.
    Friedman TS; Triboletti M; Sandusky RM; Katz S
    Am J Hosp Pharm; 1984 Oct; 41(10):2037-44. PubMed ID: 6496492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterans Administration medical center policies and procedures for handling injectable antineoplastic drugs.
    Moody DG
    Am J Hosp Pharm; 1984 May; 41(5):916-9. PubMed ID: 6731452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of guidelines for the avoidance and treatment of extravasation due to antineoplastic drugs.
    Wolfe CA; Linkewich JA
    Hosp Pharm; 1987 Feb; 22(2):125-31. PubMed ID: 10280297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicant extravasation: myths and realities.
    Boyle DM; Engelking C
    Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extravasation of chemotherapeutic agents: prevention and therapy].
    Jordan K; Grothe W; Schmoll HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicant chemotherapy extravasation antidotes and treatments.
    Schulmeister L
    Clin J Oncol Nurs; 2009 Aug; 13(4):395-8. PubMed ID: 19648094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy extravasation from implanted ports.
    Schulmeister L; Camp-Sorrell D
    Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flow sheet for follow-up after chemotherapy extravasation.
    Davis ME; DeSantis D; Klemm K
    Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extravasation management.
    Schulmeister L
    Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable-antineoplastic-drug practices in Michigan hospitals.
    Cohen IA; Newland SJ; Kirking DM
    Am J Hosp Pharm; 1987 May; 44(5):1096-105. PubMed ID: 3605120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary rounds (MDR): an implementation system for sustained improvement in the American Heart Association's Get With The Guidelines program.
    Ellrodt G; Glasener R; Cadorette B; Kradel K; Bercury C; Ferrarin A; Jewell D; Frechette C; Seckler P; Reed J; Langou A; Surapaneni N;
    Crit Pathw Cardiol; 2007 Sep; 6(3):106-16. PubMed ID: 17804970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncology pharmacy specialists in oncology].
    Ikesue H; Oishi R
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):578-82. PubMed ID: 18408426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing cytotoxic extravasation.
    Pattison J
    Nurs Times; 2002 Oct 29-Nov 4; 98(44):32-4. PubMed ID: 12451746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic drug-use process at a rural hospital.
    Parrish RH
    Hosp Pharm; 1983 May; 18(5):250-1, 255-6. PubMed ID: 10260209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.